Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intercellular adhesion molecule 1 (ICAM-1), also known as CD54, is a cell surface glycoprotein and member of the immunoglobulin superfamily. It acts as an adhesion receptor for β2 integrins, facilitating leukocyte rolling and transmigration. ICAM-1 participates in intracellular signaling pathways and contributes to immunological synapse formation. It also serves as an entry receptor for certain pathogens. Soluble ICAM-1 (sICAM-1) can modulate leukocyte binding. ICAM-1 is implicated in numerous pathological conditions and serves as a marker for inflammation.
Modulation of inflammation or immune cell trafficking (attempted, limited success)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intercellular Adhesion Molecule 1 (ICAM-1).